With the most savage type of skin cancer, melanoma, a colossal number of dangerous looking moles are really not harmful, yet has always been difficult to know without an invasive surgical biopsy.. Today dermatologists have new help in making the right call — a handheld instrument endorsed by the FDA for multispectral investigation of tissue morphology. The MelaFind optical scanner is not for definitive diagnosis finding but instead to give extra data a specialist can use in figuring out if or not to arrange a biopsy. The objective is to diminish the quantity of patients left with unnecessary biopsy scars, with the additional advantage of taking out the expense of unnecessary procedures. TheMelaFind innovation (MELA Sciences, Irvington, NY) uses missile navigation technologies originally paid for the Department of Defense to optically scan the surface of a suspicious lesion at 10 electromagnetic wavelengths. The gathered signs are handled utilizing heavy-duty algorithms and matched against a registry of 10,000 digital images of melanoma and skin disease